(GPGI) GPGI - Overview
Sector: Industrials | Industry: Metal Fabrication | Exchange: NYSE (USA) | Market Cap: 3.539m USD | Total Return: -2.1% in 12m
Avg Turnover: 41.6M
Qual. Beats: 1
Rev. Trend: -84.9%
Warnings
Share dilution 155.7% YoY
Interest Coverage Ratio -44.7 is critical
Altman Z'' -3.36 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
GPGI, Inc., formerly CompoSecure, Inc., operates through two primary business segments: high-security metal payment cards and precision injection molding solutions. The company manufactures specialized hardware for the financial services and security sectors while providing engineered tooling and aftermarket services for the food, beverage, and medical device industries.
The business model relies on technical engineering for high-barrier packaging and complex authentication products, which often require significant capital expenditure and proprietary manufacturing processes. Within the metal fabrication and injection molding sectors, companies frequently leverage long-term service contracts and aftermarket support to generate recurring revenue streams beyond initial equipment sales.
Investors can further examine these industrial fundamentals and valuation metrics at ValueRay.
Based in Somerset, New Jersey, GPGI focuses on global distribution of sustainable molding technologies and secure payment solutions. The company’s technical precision applications are critical for thinwall packaging and consumer product closures that demand strict adherence to safety and durability standards.
- Metal payment card adoption drives revenue growth in premium banking sectors
- Expansion of injection molding technology increases penetration in medical device markets
- Fluctuations in high-grade metal costs impact manufacturing margins for security products
- Cybersecurity regulatory shifts influence demand for hardware-based authentication solutions
- Global consumer spending levels dictate volume for food and beverage packaging equipment
| Net Income: -392.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -33.26 > 1.0 |
| NWC/Revenue: -3.34% < 20% (prev -9.64%; Δ 6.29% < -1%) |
| CFO/TA -0.02 > 3% & CFO -78.5m > Net Income -392.5m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (289.7m) vs 12m ago 155.7% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 3.23% > 50% (prev 128.8%; Δ -125.5% > 0%) |
| Interest Coverage Ratio: -44.65 > 6 (EBITDA TTM -75.4m / Interest Expense TTM 1.69m) |
| A: -0.00 (Total Current Assets 22.9m - Total Current Liabilities 24.9m) / Total Assets 3.41b |
| B: -0.20 (Retained Earnings -686.8m / Total Assets 3.41b) |
| C: -0.04 (EBIT TTM -75.4m / Avg Total Assets 1.85b) |
| D: -2.31 (Book Value of Equity -687.0m / Total Liabilities 297.8m) |
| Altman-Z'' = -3.36 = D |
As of May 24, 2026, the stock is trading at USD 11.96 with a total of 1,517,724 shares traded.
Over the past week, the price has changed by +2.67%,
over one month by -23.31%,
over three months by -45.01% and
over the past year by -2.09%.
GPGI has no consensus analysts rating.
P/S = 147467.02
P/B = 1.1125
Revenue TTM = 59.8m USD
EBIT TTM = -75.4m USD
EBITDA TTM = -75.4m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.53b USD (3.54b + (null Debt) - CCE 6.50m)
Interest Coverage Ratio = -44.65 (Ebit TTM -75.4m / Interest Expense TTM 1.69m)
EV/FCF = -45.23x (Enterprise Value 3.53b / FCF TTM -78.1m)
FCF Yield = -2.21% (FCF TTM -78.1m / Enterprise Value 3.53b)
FCF Margin = -130.6% (FCF TTM -78.1m / Revenue TTM 59.8m)
Net Margin = -656.1% (Net Income TTM -392.5m / Revenue TTM 59.8m)
Gross Margin = unknown ((Revenue TTM 59.8m - Cost of Revenue TTM 2.00k) / Revenue TTM)
Tobins Q-Ratio = 1.03 (Enterprise Value 3.53b / Total Assets 3.41b)
Interest Expense / Debt = unknown (Interest Expense 1.69m / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -59.5m (EBIT -75.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.92 (Total Current Assets 22.9m / Total Current Liabilities 24.9m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA -75.4m)
Debt / FCF = unknown (Net Debt none / FCF TTM -78.1m)
Total Stockholder Equity = 851.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -21.18% (Net Income -392.5m / Total Assets 3.41b)
RoE = -25.52% (Net Income TTM -392.5m / Total Stockholder Equity 1.54b)
RoCE = -2.22% (EBIT -75.4m / Capital Employed (Total Assets 3.41b - Current Liab 24.9m))
RoIC = -1.76% (negative operating profit) (NOPAT -59.5m / Invested Capital 3.39b)
WACC = 12.58% (E(3.54b)/V(3.54b) * Re(12.58%) + (debt-free company))
Discount Rate = 12.58% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 73.33 | Cagr: 232.7%
[DCF] Fair Price = unknown (Cash Flow -78.1m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.05 | # QB: 1
Revenue Correlation: -84.88 | Revenue CAGR: -60.87% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.14 | Chg30d=-43.73% | Revisions=N/A | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.23 | Chg30d=-18.00% | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=0.95 | Chg30d=-0.10% | Revisions=+20% | GrowthEPS=-3.9% | GrowthRev=+349.6%
EPS next Year (2027-12-31): EPS=1.26 | Chg30d=+8.61% | Revisions=+20% | GrowthEPS=+31.9% | GrowthRev=-17.2%
[Analyst] Revisions Ratio: +20%